BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24756111)

  • 1. Exploring the IL-21-STAT3 axis as therapeutic target for Sézary syndrome.
    van der Fits L; Out-Luiting JJ; Tensen CP; Zoutman WH; Vermeer MH
    J Invest Dermatol; 2014 Oct; 134(10):2639-2647. PubMed ID: 24756111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sézary syndrome.
    van der Fits L; Out-Luiting JJ; van Leeuwen MA; Samsom JN; Willemze R; Tensen CP; Vermeer MH
    J Invest Dermatol; 2012 Feb; 132(2):440-7. PubMed ID: 21938013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome.
    van der Fits L; van Kester MS; Qin Y; Out-Luiting JJ; Smit F; Zoutman WH; Willemze R; Tensen CP; Vermeer MH
    J Invest Dermatol; 2011 Mar; 131(3):762-8. PubMed ID: 21085192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.
    Zhang C; Li B; Gaikwad AS; Haridas V; Xu Z; Gutterman JU; Duvic M
    J Invest Dermatol; 2008 Nov; 128(11):2728-2735. PubMed ID: 18496567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells.
    Eriksen KW; Kaltoft K; Mikkelsen G; Nielsen M; Zhang Q; Geisler C; Nissen MH; Röpke C; Wasik MA; Odum N
    Leukemia; 2001 May; 15(5):787-93. PubMed ID: 11368440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cucurbitacin I inhibits Stat3 and induces apoptosis in Sézary cells.
    van Kester MS; Out-Luiting JJ; von dem Borne PA; Willemze R; Tensen CP; Vermeer MH
    J Invest Dermatol; 2008 Jul; 128(7):1691-5. PubMed ID: 18200050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOTCH1 signaling as a therapeutic target in Sézary syndrome.
    van der Fits L; Qin Y; Out-Luiting JJ; Vermeer KG; Whittaker S; van Es JH; Tensen CP; Vermeer MH
    J Invest Dermatol; 2012 Dec; 132(12):2810-7. PubMed ID: 22718117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma.
    Pan Y; Zhou F; Zhang R; Claret FX
    PLoS One; 2013; 8(1):e54565. PubMed ID: 23382914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance.
    Butler RM; McKenzie RC; Jones CL; Flanagan CE; Woollard WJ; Demontis M; Ferreira S; Tosi I; John S; Whittaker SJ; Mitchell TJ
    J Invest Dermatol; 2019 Sep; 139(9):1975-1984.e2. PubMed ID: 30910759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rGel/BLyS fusion toxin inhibits STAT3 signaling via down-regulation of interleukin-6 receptor in diffuse large B-cell lymphoma.
    Lyu MA; Sung B; Cheung LH; Marks JW; Aggarwal BB; Aguiar RC; Rosenblum MG
    Biochem Pharmacol; 2010 Nov; 80(9):1335-42. PubMed ID: 20654581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Nrf2/STAT3 axis in induction of apoptosis through sub-G
    Tajmohammadi I; Mohammadian J; Sabzichi M; Mahmuodi S; Ramezani M; Aghajani M; Ramezani F
    J Cell Biochem; 2019 Aug; 120(8):14035-14043. PubMed ID: 30993753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy with stattic enriches the anti-proliferative effect of doxorubicin in human ZR-75-1 breast cancer cells via arresting cell cycle and inducing apoptosis.
    Khaki-Khatibi F; Ghorbani M; Sabzichi M; Ramezani F; Mohammadian J
    Biomed Pharmacother; 2019 Jan; 109():1240-1248. PubMed ID: 30551374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Acetyl cysteine prevents activities of STAT3 inhibitors, Stattic and BP-1-102 independently of its antioxidant properties.
    Uchihara Y; Ohe T; Mashino T; Kidokoro T; Tago K; Tamura H; Funakoshi-Tago M
    Pharmacol Rep; 2019 Dec; 71(6):1067-1078. PubMed ID: 31627175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
    Wang H; Tao Z; Feng M; Li X; Deng Z; Zhao G; Yin H; Pan T; Chen G; Feng Z; Li Y; Zhou Y
    Biochem Biophys Res Commun; 2020 Dec; 533(3):368-375. PubMed ID: 32962858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
    Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
    Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-26 promotes the proliferation and survival of human gastric cancer cells by regulating the balance of STAT1 and STAT3 activation.
    You W; Tang Q; Zhang C; Wu J; Gu C; Wu Z; Li X
    PLoS One; 2013; 8(5):e63588. PubMed ID: 23704922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The STAT3 inhibitor Stattic acts independently of STAT3 to decrease histone acetylation and modulate gene expression.
    Poria DK; Sheshadri N; Balamurugan K; Sharan S; Sterneck E
    J Biol Chem; 2021; 296():100220. PubMed ID: 33839684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoural cells to chemotherapeutic drugs.
    Butturini E; Carcereri de Prati A; Chiavegato G; Rigo A; Cavalieri E; Darra E; Mariotto S
    Free Radic Biol Med; 2013 Dec; 65():1322-1330. PubMed ID: 24095958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncogenic effects of constitutive Stat3 signaling in salivary gland cancer cells are mediated by survivin and modulated by the NSAID sulindac.
    Nikitakis NG; Scheper MA; Papanikolaou VS; Sauk JJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jun; 107(6):826-36. PubMed ID: 19272804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.